Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer
2005 · New England Journal of Medicine · 5,074 citations
https://doi.org/10.1056/nejmoa052306
M
Martine Piccart
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
1.6K
Papers
114.7K
Citations
149
h-index
664
i10-index
Martine Piccart is an academic researcher from Université Libre de Bruxelles. The author has contributed to research in topics: HER2/EGFR in Cancer Research & Breast Cancer Treatment Studies & Cancer Treatment and Pharmacology. The author has an h-index of 149, co-authored 1318 publications.
ORCID: 0000-0001-9068-8504Papers by this author
worksPathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
2014 · The Lancet · 4,585 citations
https://doi.org/10.1016/s0140-6736(13)62422-8
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
2013 · Annals of Oncology · 3,628 citations
https://doi.org/10.1093/annonc/mdt303
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
2013 · Annals of Oncology · 3,628 citations
https://doi.org/10.1093/annonc/mdt303
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
2016 · Annals of Oncology · 2,052 citations
https://doi.org/10.1093/annonc/mdw544
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
2016 · New England Journal of Medicine · 1,957 citations
https://doi.org/10.1056/nejmoa1602253
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat